Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 9803846, 8 pages
http://dx.doi.org/10.1155/2016/9803846
Research Article

Protective Effect of an Antibody against Specific Extracellular Domain of TLR2 on Agonists-Driven Inflammatory and Allergic Response

1Department of Burns and Plastics, The People’s Hospital of Anyang City, Anyang, Henan 455000, China
2The Institute of Nephrology, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, China

Received 22 January 2016; Revised 30 March 2016; Accepted 4 April 2016

Academic Editor: Gjumrakch Aliev

Copyright © 2016 Tianwu Guo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. McCurdy, T. J. Olynych, L. H. Maher, and J. S. Marshall, “Cutting edge: distinct toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells,” The Journal of Immunology, vol. 170, no. 4, pp. 1625–1629, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Redecke, H. Häcker, S. K. Datta et al., “Cutting edge: activation of toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma,” The Journal of Immunology, vol. 172, no. 5, pp. 2739–2743, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Takeda and S. Akira, “Toll-like receptors in innate immunity,” International Immunology, vol. 17, no. 1, pp. 1–14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. C. N. Serhan, P. A. Ward, and D. W. Gilroy, Fundamentals of Inflammation, Cambridge University Press, Cambridge, UK, 2010.
  5. S. Bauer, D. Hangel, and P. Yu, “Immunobiology of toll-like receptors in allergic disease,” Immunobiology, vol. 212, no. 6, pp. 521–533, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Han, J. Zhong, W. Wei et al., “Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice,” Diabetes, vol. 57, no. 8, pp. 2118–2127, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Urbonaviciute, B. G. Fürnrohr, S. Meister et al., “Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE,” Journal of Experimental Medicine, vol. 205, no. 13, pp. 3007–3018, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. C. A. Akdis, F. Kussebi, B. Pulendran et al., “Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides,” European Journal of Immunology, vol. 33, no. 10, pp. 2717–2726, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Kanzler, F. J. Barrat, E. M. Hessel, and R. L. Coffman, “Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists,” Nature Medicine, vol. 13, no. 5, pp. 552–559, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Z. Zhao, Y. J. Liu, P. Zhu, J. Liu, Q. T. Han, and N. Fu, “Inhibition of fibrosarcoma growth in mice by antibody against B cell epitope on mouse Toll-like receptor-2 extracellular domain,” Academic Journal of the First Medical College of PLA, vol. 24, no. 8, pp. 873–876, 2004 (Chinese). View at Google Scholar
  11. D. Iwaki, H. Mitsuzawa, S. Murakami et al., “The extracellular toll-like receptor 2 domain directly binds peptidoglycan derived from Staphylococcus aureus,” The Journal of Biological Chemistry, vol. 277, no. 27, pp. 24315–24320, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Vasselon, P. A. Detmers, D. Charron, and A. Haziot, “TLR2 recognizes a bacterial lipopeptide through direct binding,” The Journal of Immunology, vol. 173, no. 12, pp. 7401–7405, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Fujita, T. Into, M. Yasuda et al., “Involvement of leucine residues at positions 107, 112, and 115 in a leucine-rich repeat motif of human Toll-like receptor 2 in the recognition of diacylated lipoproteins and lipopeptides and Staphylococcus aureus peptidoglycans,” The Journal of Immunology, vol. 171, no. 7, pp. 3675–3683, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Vasselon, W. A. Hanlon, S. D. Wright, and P. A. Detmers, “Toll-like receptor 2 (TLR2) mediates activation of stress-activated MAP kinase p38,” Journal of Leukocyte Biology, vol. 71, no. 3, pp. 503–510, 2002. View at Google Scholar · View at Scopus
  15. M. Ben-Ali, M.-R. Barbouche, S. Bousnina, A. Chabbou, and K. Dellagi, “Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients,” Clinical and Diagnostic Laboratory Immunology, vol. 11, no. 3, pp. 625–626, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Gambhir, C. Yildiz, R. Mulder et al., “The TLR2 agonists lipoteichoic acid and Pam3CSK4 induce greater pro-inflammatory responses than inactivated Mycobacterium butyricum,” Cellular Immunology, vol. 280, no. 1, pp. 101–107, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Tadmor, Y. Pozniak, T. B. Golani et al., “Listeria monocytogenes MDR transporters are involved in LTA synthesis and triggering of innate immunity during infection,” Frontiers in Cellular and Infection Microbiology, vol. 4, article 16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. N. W. J. Schröder, S. Morath, C. Alexander et al., “Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved,” The Journal of Biological Chemistry, vol. 278, no. 18, pp. 15587–15594, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. B. K. Park, H. Zhang, Q. Zeng et al., “NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF,” Nature Medicine, vol. 13, no. 1, pp. 62–69, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. W. Xie, Y. Huang, W. Xie, A. Guo, and W. Wu, “Bacteria peptidoglycan promoted breast cancer cell invasiveness and adhesiveness by targeting toll-like receptor 2 in the cancer cells,” PLoS ONE, vol. 5, no. 5, Article ID e10850, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. P. F.-Y. Cheung, C.-K. Wong, W.-K. Ip, and C. W.-K. Lam, “FAK-mediated activation of ERK for eosinophil migration: a novel mechanism for infection-induced allergic inflammation,” International Immunology, vol. 20, no. 3, pp. 353–363, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Kasakura, K. Takahashi, T. Aizawa, A. Hosono, and S. Kaminogawa, “A TLR2 ligand suppresses allergic inflammatory reactions by acting directly on mast cells,” International Archives of Allergy and Immunology, vol. 150, no. 4, pp. 359–369, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Barboza, N. O. S. Câmara, E. Gomes et al., “Endotoxin exposure during sensitization to Blomia tropicalis allergens shifts TH2 immunity towards a TH17-mediated airway neutrophilic inflammation: role of TLR4 and TLR2,” PLoS ONE, vol. 8, no. 6, Article ID e67115, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. M. C. Nawijn, A. C. Motta, R. Gras, S. Shirinbak, H. Maazi, and A. J. M. van Oosterhout, “TLR-2 activation induces regulatory T cells and long-term suppression of asthma manifestations in mice,” PLoS ONE, vol. 8, no. 2, Article ID e55307, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Haapakoski, P. Karisola, N. Fyhrquist et al., “Toll-like receptor activation during cutaneous allergen sensitization blocks development of asthma through IFN-gamma-dependent mechanisms,” Journal of Investigative Dermatology, vol. 133, no. 4, pp. 964–972, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. K. Krishnaswamy, A. C. Jirmo, A. M. Baru et al., “Toll-like receptor-2 agonist-allergen coupling efficiently redirects Th2 cell responses and inhibits allergic airway eosinophilia,” American Journal of Respiratory Cell and Molecular Biology, vol. 47, no. 6, pp. 852–863, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. J. Duechs, C. Hahn, E. Benediktus et al., “TLR agonist mediated suppression of allergic responses is associated with increased innate inflammation in the airways,” Pulmonary Pharmacology and Therapeutics, vol. 24, no. 2, pp. 203–214, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. K. Cho, M. K. Park, S. A. Kang et al., “TLR2-dependent amelioration of allergic airway inflammation by parasitic nematode type II MIF in mice,” Parasite Immunology, vol. 37, no. 4, pp. 180–191, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Yamasaki and T. Saito, “Progress in allergy signal research on mast cells: signal regulation of multiple mast cell responses through FcεRI,” Journal of Pharmacological Sciences, vol. 106, no. 3, pp. 336–340, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Chisholm, L. Libet, T. Hayashi, and A. A. Horner, “Airway peptidoglycan and immunostimulatory DNA exposures have divergent effects on the development of airway allergen hypersensitivities,” Journal of Allergy and Clinical Immunology, vol. 113, no. 3, pp. 448–454, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Yu, K. H. Yip, I. Y. S. Tam et al., “Differential effects of the Toll-like receptor 2 agonists, PGN and Pam3CSK4 on anti-IgE induced human mast cell activation,” PLoS ONE, vol. 9, no. 11, Article ID e112989, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. B. P. Tancowny, V. Karpov, R. P. Schleimer, and M. Kulka, “Substance P primes lipoteichoic acid- and Pam3CysSerLys4-mediated activation of human mast cells by up-regulating Toll-like receptor 2,” Immunology, vol. 131, no. 2, pp. 220–230, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Brzezińska-Błaszczyk and M. Wierzbicki, “Mast cell Toll-like receptors (TLRs),” Postepy Higieny i Medycyny Doswiadczalnej, vol. 64, pp. 11–21, 2010. View at Google Scholar · View at Scopus
  34. A. S. Kirshenbaum, E. Swindle, M. Kulka, Y. Wu, and D. D. Metcalfe, “Effect of lipopolysaccharide (LPS) and peptidoglycan (PGN) on human mast cell numbers, cytokine production, and protease composition,” BMC Immunology, vol. 9, article 45, 2008. View at Publisher · View at Google Scholar · View at Scopus